Science
DeepBAR: AI-Based Technique That May Speed Drug Discovery – Genetic Engineering & Biotechnology News
DeepBAR is a new technique that combines chemistry and machine learning to speed up calculations of drug molecules’ binding affinity to proteins.
A new technique, DeepBAR, quickly calculates the binding affinities between drug candidates and their targets. The approach, which combines chemistry and machine learning, could lower a hurdle in the drug discovery process. DeepBAR yields precise calculations in a fraction of the time compared to previous state-of-the-art methods. The inventors say DeepBAR could one day quicken the pace of drug discovery and protein engineering.
“Our method is orders of magnitude faster than before, meaning we can…
-
General17 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General9 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General16 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
General21 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat